- Home
- Applications
- vaccination
Refine by
Vaccination Product Applications For The Medical Health Care Industry
12 applications found
Enable different strategies for vaccine development to attack rapidly mutating viruses such as influenza, HCV, HIV, or coronaviruses. Use our platform to assist in the creation and optimization of different types of vaccines such as virus-like particles (VLPs), DNA vaccines, RNA ...
ByTeselaGen Biotechnology, Inc. based in Portola Valley, CALIFORNIA (USA)
Because the BacVax method is based on genomic and structural vaccinology, any bacteria can be analyzed for targets. Our vaccines will be able to address bacterial infections that currently have no vaccine options available, and we are ready to fill that ...
ByBacVax, Inc. based in Phoenix, ARIZONA (USA)
Immune repertoire analysis has taken a predominant role in the development of vaccination strategies against infectious disease and has enabled characterization of the immune response against pathogens at high ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Current viral titer assay methods, a crucial component of vaccine & CGT development and production efforts, are generally slow, labor intensive, subjective, and difficult to standardize, often resulting in large errors or failures during critical production ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)
As the COVID-19 pandemic continues, the SARS-CoV-2 virus is likely to become endemic with emerging novel variants, some of them seasonal. Updates to the various vaccines will be required, as will a range of anti-virals with a variety of mechanisms of action, for use in early infection and in hospitalizated patients, much like oseltamivir (Tamiflu) is used in certain populations for seasonal ...
ByCyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA)
2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. ...
By2A Pharma ApS based in Aalborg Øst, DENMARK
The manufacture of biopharmaceutical agents such as therapeutic monoclonal antibodies, vaccines and cell-based therapies like CAR-T cells require the highest quality control against the contamination of adventitious agents. ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
The Flow NanoAnalyzer is designed to be an instrumental tool in the fields of life sciences, nanoscience, and nanotechnology. It facilitates the detailed analysis of both natural and synthetic nanoparticles ranging from 7 to 1000 nanometers at a single-particle level. Key applications include the characterization of extracellular vesicles, mitochondria, bacteria, viruses, nanomedicine, and nanomaterials. This device utilizes a combination of light scattering and fluorescence detection to deliver a high-resolution ...
ByNanoFCM based in Nottinghamshire, UNITED KINGDOM
At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. The severity and rapid spread of COVID-19 (caused by SARS-CoV-2), resulted in a global pandemic declared by the World Health Organization in March 2020. The virus has spread to more than 100 countries, including the United ...
ByNovavax based in Gaithersburg, MARYLAND (USA)
Influenza, commonly known as “the flu”, is an infectious disease caused by an influenza virus that is spread by droplet transmission through the air from coughs and sneezes or by touching surfaces contaminated with the virus. Symptoms can be mild to severe with the most common including a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. More severe complications ...
ByFluGen, Inc. based in Madison, WISCONSIN (USA)
Predict Health Monitoring provides online Occupational Health Screening Assessment Tools, giving insight into the health status of your work force at any one ...
ByEnigma based in Auckland, NEW ZEALAND
Maximize the probability of your clinical trial success by accelerating patient enrollment and flexible operations. Whether it is investigator-initiated study, observational study, phase 0, 1, 2, 3, or 4 post-market trials, real-world evidence generation to supplement your randomized controlled clinical trial, maximizing the speed of patient enrollment is the proven way to minimize your ...
ByJeeva Informatics Solutions Inc. based in Manassas, VIRGINIA (USA)